Lifecore Current Deferred Revenue from 2010 to 2025
| LFCR Stock | 5.76 0.16 2.86% |
Current Deferred Revenue | First Reported 1997-05-31 | Previous Quarter 654 K | Current Value 937 K | Quarterly Volatility 3.4 M |
Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.4 M, Interest Expense of 21.8 M or Total Revenue of 140.1 M, as well as many indicators such as Price To Sales Ratio of 0.2, Dividend Yield of 0.0 or PTB Ratio of 0.74. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.
Lifecore | Current Deferred Revenue |
Latest Lifecore Biomedical's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Lifecore Biomedical over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Lifecore Biomedical's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lifecore Biomedical's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Lifecore Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 1,188,506 | |
| Geometric Mean | 932,834 | |
| Coefficient Of Variation | 64.79 | |
| Mean Deviation | 591,320 | |
| Median | 1,130,000 | |
| Standard Deviation | 770,064 | |
| Sample Variance | 593B | |
| Range | 2.5M | |
| R-Value | 0.08 | |
| Mean Square Error | 631B | |
| R-Squared | 0.01 | |
| Significance | 0.76 | |
| Slope | 13,388 | |
| Total Sum of Squares | 8.9T |
Lifecore Current Deferred Revenue History
About Lifecore Biomedical Financial Statements
Lifecore Biomedical shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifecore Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.9 M | 1.3 M |
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.